268 related articles for article (PubMed ID: 29495537)
1. DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.
Ajamian L; Melnychuk L; Jean-Pierre P; Zaharatos GJ
Viruses; 2018 Feb; 10(3):. PubMed ID: 29495537
[TBL] [Abstract][Full Text] [Related]
2. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
Melnychuk L; Ajamian L; Jean-Pierre P; Liang J; Gheorghe R; Wainberg MA; Zaharatos GJ
Vaccine; 2017 May; 35(20):2736-2744. PubMed ID: 28392143
[TBL] [Abstract][Full Text] [Related]
3. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
[TBL] [Abstract][Full Text] [Related]
4. Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvants.
Biedma ME; Cayet D; Tabareau J; Rossi AH; Ivičak-Kocjan K; Moreno G; Errea A; Soulard D; Parisi G; Jerala R; Berguer P; Rumbo M; Sirard JC
Vaccine; 2019 Jan; 37(4):652-663. PubMed ID: 30583910
[TBL] [Abstract][Full Text] [Related]
5. FliC's Hypervariable D3 Domain Is Required for Robust Anti-Flagellin Primary Antibody Responses.
López-Yglesias AH; Lu CC; Zhao X; Chou T; VandenBos T; Strong RK; Smith KD
Immunohorizons; 2019 Sep; 3(9):422-432. PubMed ID: 31488506
[TBL] [Abstract][Full Text] [Related]
6. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
7. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
Mohan T; Verma P; Rao DN
Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
[TBL] [Abstract][Full Text] [Related]
8. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope.
Li J; Chen X; Jiang S; Chen YH
Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167
[TBL] [Abstract][Full Text] [Related]
9. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.
Kim M; Song L; Moon J; Sun ZY; Bershteyn A; Hanson M; Cain D; Goka S; Kelsoe G; Wagner G; Irvine D; Reinherz EL
J Biol Chem; 2013 Nov; 288(44):31888-901. PubMed ID: 24047898
[TBL] [Abstract][Full Text] [Related]
11. Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.
Zhai Y; Zhong Z; Zariffard M; Spear GT; Qiao L
Vaccine; 2013 Nov; 31(46):5422-9. PubMed ID: 24055348
[TBL] [Abstract][Full Text] [Related]
12. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
Rostami H; Ebtekar M; Ardestani MS; Yazdi MH; Mahdavi M
Immunol Lett; 2017 Jul; 187():19-26. PubMed ID: 28479111
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.
Habte HH; Banerjee S; Shi H; Qin Y; Cho MW
Virology; 2015 Dec; 486():187-97. PubMed ID: 26454663
[TBL] [Abstract][Full Text] [Related]
14. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
[TBL] [Abstract][Full Text] [Related]
15. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
16. Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.
Hanson MC; Abraham W; Crespo MP; Chen SH; Liu H; Szeto GL; Kim M; Reinherz EL; Irvine DJ
Vaccine; 2015 Feb; 33(7):861-8. PubMed ID: 25559188
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.
Bradley T; Trama A; Tumba N; Gray E; Lu X; Madani N; Jahanbakhsh F; Eaton A; Xia SM; Parks R; Lloyd KE; Sutherland LL; Scearce RM; Bowman CM; Barnett S; Abdool-Karim SS; Boyd SD; Melillo B; Smith AB; Sodroski J; Kepler TB; Alam SM; Gao F; Bonsignori M; Liao HX; Moody MA; Montefiori D; Santra S; Morris L; Haynes BF
EBioMedicine; 2016 Oct; 12():196-207. PubMed ID: 27612593
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
Montero M; Gulzar N; Klaric KA; Donald JE; Lepik C; Wu S; Tsai S; Julien JP; Hessell AJ; Wang S; Lu S; Burton DR; Pai EF; Degrado WF; Scott JK
J Virol; 2012 Mar; 86(6):2930-41. PubMed ID: 22238313
[TBL] [Abstract][Full Text] [Related]
19. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
Perez LG; Costa MR; Todd CA; Haynes BF; Montefiori DC
J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
